NCT00941265View on ClinicalTrials.gov

Effect of Dopaminergic Medication on Recovery of Aphasia

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Aphasia
Interventions
DRUG

levodopa and benserazide

Daily Monday to Friday CAT with Daily Monday to Friday levodopa 100 mg with benserazide 25 mg , in the morning 1 h after breakfast, during 2 weeks .

DRUG

placebo

Daily CAT Monday to Friday with daily placebo Monday to Friday , in the morning 1 h after breakfast, taken 5 out of 7 days during the 2 weeks of one of the two treatment periods.

Trial Locations (1)

Unknown

Neurorééducation, University Hospital, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT00941265 - Effect of Dopaminergic Medication on Recovery of Aphasia | Biotech Hunter | Biotech Hunter